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Abstract
Background: 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), a heterocyclic aromatic amine (HCA) formed
in meat that is cooked at high temperatures and then ingested, can potentially be retained in human adipose
tissues.
Methods: To determine if PhIP is bioactive in the adipocyte, we exposed a human adipocyte cell line,HepG2 and
Caco-2 cells to low dose PhIP. Uptake and retention of PhIP was determined and cytotoxicity was assessed by the
TUNEL assay. Relative expression of PhIP-activating genes (CYP1A1, CYP1A2, SULT1A1 and UGT1A1) was determined
by RT-PCR and global expression changes were also examined.
Results: The percent retention of 0.1 μCi [14C]-PhIP over a 24 h period was significantly higher in the adipocyte than
the HepG2 (p = 0.0001) and Caco-2 (p = 0.0007) cell lines. Cytotoxicity rates were 14.4 and 2.6 % higher compared to
controls in Caco-2 and HepG2 cells (p < 0.001 and 0.054, respectively); no significant differences were detected in
adipocyte cells (p = 0.18). Caco-2 and HepG2 cells, respectively, had significantly higher basal expression of
CYP1A1 (p = 0.001, p = 0.003), SULT1A1 (p = 0.04, p < 0.001) and UGT1A1 (p < 0.001, p = 0.01) compared to the
adipocyte. Exposure to 5nM PhIP did not significantly induce expression of these genes in any of the cell lines.
Global gene expression analysis of mature adipocytes exposed to 5nM PhIP for 72 h resulted in statistically
significant changes in 8 genes (ANGPTL2, CD14, CIDEA, EGR1, FOS, IGFBP5, PALM and PSAT1). Gene-gene interaction
and pathway analysis indicates that PhIP modulates genes controlled by the STAT3 transcriptional factor and
initiates leptin signaling via the JAK/STAT and MAPK pathway cascades. Early growth response 1 (EGR1) and
prostaglandin synthase 2 (COX-2) were down-regulated via c-Fos, while insulin binding protein 5 (IBP5) was up
regulated. Expression of transcription factors (ANGPTL2, HP, LEP, SAA1, SAA2), genes related to inflammation
(SAA1, LEP), diabetes (IGFBP5) and cancer risk (SAA2) were also elevated upon exposure to 5 nM PhIP..
Conclusions: PhIP mediates gene expression changes within the adipocyte, and the pathways most affected are
related to cancer and other chronic diseases. Further studies are needed on the relationship between dietary
carcinogens such as PhIP with cancer, obesity and diabetes.
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Background
Heterocyclic aromatic amines (HCAs) are dietary chemi-
cals formed when muscle meat is cooked at high tempera-
tures, such as broiling, frying or grilling. Lipids make up
70 % of white adipose tissue in humans and this endocrine
organ represents a reservoir for many lipophilic contami-
nants [1, 2]. The most abundant lipophilic HCA in cooked
meat is 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyri-
dine (PhIP) [3]. PhIP is a procarcinogen that is meta-
bolically activated by cytochromes P450 (CYP) 1A1 and
1A2 to form the metabolite, N-hydroxy-PhIP (N2-OH-
PhIP) [4–6]. N 2-OH-PhIP can then undergo detoxifica-
tion reactions (i.e. glucuronidation) or reactions that
generate reactive metabolites (i.e. sulfation) [7–9]. N2–
OH-PhIP metabolites induce chromosomal aberrations
[10], form PhIP-DNA adducts in colon mucosa [10], and
causes colon and mammary carcinomas in animal models
[11–16]. The current consensus in the literature is that
consumption of well-done meat is associated with both el-
evated cancer risk and mortality [17]. However, case con-
trol studies examining meat consumption, HCA content
and cancer risk lack concordance. Conflicting reports in
the literature are almost certainly influenced by the diffi-
culty of quantifying exposures, since HCA content can
vary 100-fold depending on cooking temperature [18].
Additionally, the interaction between adiposity, HCA ex-
posure and cancer risk is poorly understood.
Obesity is overtaking under-nutrition and infectious
diseases as the most significant causes of ill-health [19].
Obesity is also predicted to have the major influence on
cancer incidence, since overweight and obesity are rec-
ognized risk factors for various cancers [20]. In addition
to its role as an endocrine organ, adipose tissue acts as a
reservoir for a large fraction of lipophilic contaminants,
including persistent organic pollutants, or POP [21]. A
study of the distribution of radiolabeled PhIP in mice
demonstrated that after administration of a single diet-
ary equivalent dose of PhIP, the highest concentrations
were detected in the stomach, intestine and adipose tis-
sue [22]. Others have reported that human mammary
lipid can be mutagenic, and although the identity of the
mutagens was not confirmed, the lipid was isolated
using a solid-phase tandem extraction procedure origin-
ally developed for extraction of heterocyclic amines. The
presence of substances in extracts of essentially normal
human mammary lipid induced point mutation in bac-
teria in the presence of metabolizing enzymes and
chromosomal damage (signaled by micronucleus forma-
tion) in metabolically competent human cells [23].
In the current study, we compared the uptake and re-
tention of PhIP into a human adipocyte cell line (differ-
entiated from human mesenchymal stem cells, (hMSC)),
in comparison with a hepatocellular cell line (HepG2)
and a colorectal cell line (Caco-2) in order to determine
if there were differences. We also compared the ability
of PhIP to induce DNA damage and subsequent cell
death in these three cell lines. We examined the ability
of PhIP to induce gene expression changes in PhIP
metabolizing enzymes in each of the cell lines. Finally,
global changes in gene expression in the PhIP-exposed
adipocyte cell line were also explored.
Methods
Cell culture and differentiation
The identity of all cell lines was confirmed by submis-
sion to American Type Culture Collection (ATCC)
(Manassas, VA) for analysis by short tandem repeat
methodology on December 9, 2015. Human Mesenchy-
mal Stem Cells (hMSC) were obtained from AllCells
(Emeryville, CA). The hMSCs were expanded in growth
medium (GM) consisting of alpha Minimum Essential
Medium (αMEM), supplemented with 16.5 % fetal bo-
vine serum (FBS) (Tissue Cultures Biologicals, Long
Beach, CA), 2 mM L-glutamine (Sigma-Aldrich, St.
Louis, MO), and penicillin/streptomycin at a concentra-
tion of 100 μg/ml each (Thermo Fisher Scientific,
Watham, MA), in a humidified incubator at 37 °C, with
5 % CO2. Cells were seeded 2.0 × 10
5 cells/well in 6 well
plates (for RNA isolation) or 2.0 × 104 /well in 24 well
plates (for uptake/retention experiments). Fat differenti-
ation medium (FDM), composed of GM supplemented
with 0.5 μM dexamethasone, 0.5 μM isobutylmethyl-
xanthine and 50 μM indomethacin (Sigma-Aldrich, St.
Louis, MO), was used to initiate adipocyte differentiation.
Fresh FDM was applied every 3-4 days. Differentiation
reached a lipid maximum around day 21 at which time
PhIP treatments began. Correlation of differentiated vs
undifferentiated hMSC was determined by AdipoRed™
Assay Reagent (Lonza Walkersville, Inc. Walkersville,
MD) and Trypan Blue (Sigma-Aldrich, St. Louis, MO)
readings using a SpectraMax M5 Molecular Devices
(VWR, Atlanta, GA) (R2 = 0.9826).
HepG2 and Caco-2 cell lines were purchased from
ATCC and maintained following the protocol described
by ATCC at 37 °C in an incubator containing 5 % CO2.
HepG2 and Caco-2 cells were cultured in EMEM+ L-
glutamine (ATCC) supplemented with 10 % FBS and
EMEM (ATCC) 20 % FBS, respectively. Penicillin/
streptomycin at a concentration of 100 μg/ml (Thermo
Fisher, Watham, MA) was added to both media.
Uptake of [14C]-PhIP into human cell lines
All cell lines were treated with 5 μM unlabeled PhIP plus
0.1 μCi [14C]-PhIP (Toronto Research Chemicals,
Toronto, Ontario, Canada) in 0.5 ml FDM using dimethyl
sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO) as
vehicle for all PhIP exposures. The PhIP solution was di-
luted in culture medium and cells were exposed for 0, 5,
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7, 15, 60 and 300 s (s). The cells were then lysed with
100 μl RNAqueous lysis buffer solution (Ambion by Life
Technologies Corp., Austin, TX) and the lysate was trans-
ferred to a Polyethylene Terephthalate (PET) 24 well sam-
ple counting plate containing 300 μl OptiPhase SuperMix
scintillation cocktail (Perkins Elmer, Waltham, MA). Sam-
ple scintillation counting in corrected cycles per minute
(CCPM) was read using the MicroBeta Trilux 1450 LSC
and Luminescence Counter (Perkin Elmer, Waltham, MA).
Samples were run in triplicate and comparisons between
cell types were assessed by t-test.
Release of [14C]-PhIP from human cell lines
Cell lines were plated as described for the uptake stud-
ies. Each well was treated with 5 μM unlabeled PhIP
plus 0.1 μCi 14C-PhIP in FDM using DMSO as vehicle
and allowed to reach equilibrium for 30 min. The
medium (100 μl) was then transferred to PET 24 well
sample counting plates containing 300 μl OptiPhase
SuperMix scintillation cocktail for counting. Fresh
medium (0.5 ml) was applied to the cells, and then
removed after 0, 0.5, 1, 2, 5, 15, 60 and 1440 min of
exposure. 100 μl aliquots of the fresh medium were
transferred to scintillation plates. Cells were then lysed
with 100 μl lysis buffer and the lysate was transferred to
scintillation plates and CCPM were recorded.
TUNEL assay
Cells were plated at 1.0 × 104 per well onto Lab-Tek 8
well Chamber Slides (Nalge Nunc International, Roches-
ter, NY) and allowed to grow overnight in a humidified
incubator at 37 °C, with 5 % CO2. Adipocytes were
allowed to differentiate using medium described above
for 21 days. Quadruplicate cell samples were exposed to
vehicle or PhIP (5 μM) up to 72 h. TUNEL assays were
performed using the In Situ Cell Death Detection Kit
(Roche Diagnostics, Indianapolis, IN) following the man-
ufacturer’s protocol. A set of short band filters with re-
spective emission and excitation wavelengths were used
for the green spectrum (FITC) and blue spectrum
(DAPI) for the TUNEL-positive objects and nuclei,
respectively.
Effect of PhIP exposure on expression of PhIP-
metabolizing enzymes in human cell lines
Changes in the expression of PhIP- metabolizing en-
zymes were assessed in HepG2, Caco-2 and hMSC-
derived adipocytes seeded at 2 × 105 cells/well in 6- well
plates. Medium containing vehicle (DMSO) or PhIP at a
final concentration of 5 nM was applied, and the cells
were returned to the incubator. All assays were per-
formed in triplicate. Medium with vehicle or PhIP was
replaced daily. After 72 h, the cells were washed in ice-
cold Dulbecco’s phosphate-buffered saline (DPBS)
(Cellgro, Thermo Fisher Scientific, Watham, MA), lysed
and total RNA was isolated using the RNAqueous Kit
(Ambion). RNA quality and quantity was measured
using a NanoDropTM 8000 Spectrophotometer (Thermo
Fisher Scientific, Watham, MA). The resulting RNA ab-
sorption 260/280 nm ratio was 2.0, indicating that the
RNA prep was pure. cDNA was generated using 1 μg
RNA with High Capacity RNA to cDNA Reverse Tran-
scription Reagent (Life Technologies Corp., Austin, TX)
and thermo cycler conditions of 37 °C for 60 min,
followed by 95 °C for 5 mins using the GeneAMP 7900
PCR System (Applied Biosystems by Life Technologies
Corp., Austin, TX). The resulting cDNA was diluted
1:20 prior to use in real-time RT-PCR.
Real-time PCR of target genes known to metabolize
PhIP was performed on the 7900HT cycler (Applied Bio-
systems, by Life Technologies Corp., Austin, TX) under
the following conditions: 95 °C for 10 min, 40 cycles of
95 °C for 1 s, followed by 60 °C for 20 s. A dissociation
cycle of 95 °C for 15 s, 60 °C for 15 s and 95 °C for 15 s
was performed at the end of each PCR reaction to en-
sure the amplicon specificity. Fast SYBR Green PCR Mas-
ter Mix (Applied Biosystems, by Life Technologies Corp.,
Austin, TX) was used along with 5 μM of primer purchased
from Integrated DNA Technologies (Coralville, IA). Primer
sequences are available in Table 1. Expression was normal-
ized to the endogenous control reference gene HRPT1.
HRPT1 was identified as “Best Gene” by Normfinder soft-
ware [24] using gene stability values compared with β-
Actin and GAPDH in all three cell types over treatments.
Expression was quantified using the relative gene expres-
sion 2 -ΔΔCT method [25].
Global gene expression analysis
hMSC cells were differentiated and exposed to varying
concentrations of PhIP for 72 h. RNA was isolated by
the method described above. RNA integrity was analyzed
on an Agilent 2100 Bioanalyzer (Agilent, Santa Clara,
CA, USA). Total RNA (500 ng) was used to generate
cRNA for hybridization with the Illumina TotalPrep™
RNA Amplification Kit (Life Technologies) according to
the manufacturer’s instructions. Microarray analysis was
performed at the University of Arkansas for Medical Sci-
ences Genomics Core. 750 ng cRNA was used for
hybridization to Illumina HumanHT-12_v4_BeadChip
for Gene Expression according to the manufacturer’s
protocol. BeadChips were scanned with the Illumina
iScan system, and data collected using GenomeStudio
software v2011.1. Data was generated using the gene ex-
pression module of Illumina Genome Studio software
after quality control analysis. The expression intensities
were median-normalized after log transformation. Dif-
ferentially expressed genes were determined using an
empirical Bayes test implemented in Linear Models for
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Microarray Data (Limma) package. A fold-change > 1.5
and p-value < 0.05 were chosen as the cutoff criteria for
screening differentially expressed genes. The p-values
were adjusted for multiple testing by controlling the
false discovery rate according to the Benjamini Hoch-
berg method. All analyses were conducted using the R
statistical environment (R Foundation for Statistical
Computing, Vienna, Austria).
Pathway analysis
Functional profiling of differentially affected biological
processes, functions, pathways, and networks for the dif-
ferentially expressed genes (DEGs) were evaluated using
open source tools and the commercial pathway packages
Metacore (MetacoreTM, www.genego.com), DAVID and
STRING databases. Differentially expressed transcripts
were mapped to the top most differentially expressed
pathways and process networks. For network analysis of
differentially expressed genes, Metacore was employed
to identify any direct interactions amongst the DEGs.
STRING database was also used to explore the gene-
gene interactions based on experimental evidence and
predictions based on homology, text mining, and co-
occurrence.
Statistical analysis
Uptake and retention data was reported as the percent
of total [14C]-PhIP that remained in cell lysate at various
time points. Percent means ± SD of triplicate measure-
ments and unpaired Student t-tests were employed to
identify significant differences between the cell lines.
Differential gene expression was determined by the 2-
ΔΔCT method [24] and reported as mean ± SD of tripli-
cate measurements. The comparisons of significance
were carried out by unpaired Student’s t-test. Cytotox-
icity was assessed by unpaired t-tests
Results
Uptake and retention of [14C] Up-PhIP in cell lines
Uptake of [14C]-PhIP into Caco-2, HepG2 and hMSC
derived adipocyte (at 70 % differentiation) cells was rapid
in all cell lines. Maximal uptake of [14C]-PhIP was ap-
parent after 5 s of exposure in HepG2 and Caco-2 cell
lines and remained unchanged over the time course of
the experiment. Overall, Caco-2 and HepG2 cells did
not differ significantly. Uptake of [14C]-PhIP into adipo-
cytes was significantly higher than into Caco-2 and
HepG2 cells at 60 s and 300 s, respectively, and did not
appear to plateau throughout the time course of the ex-
periment (Fig. 1a). When levels of [14C]-PhIP retained in
the cell lines were examined, adipocyte cell [14C]-PhIP
content was significantly higher than in Caco-2 and
HepG2 cells at all of the time points (Fig. 1b).
Cytotoxicity of PhIP to human cell lines
PhIP and other HCAs are genotoxic and cytotoxic at
high doses and induction of cell death (apoptosis) is cell-
type specific [26–28]. In order to determine if PhIP had
adverse effects at low concentrations and in adipocytes,
we exposed Caco-2, HepG2 and adipocyte cells to 5 μM
PhIP for 72 h. Irreversible cell death associated with
Table 1 Primer sequences
Symbol Forward Primer Reverse Primer Accession number
CYP1A1 GATCCCAGGCTCCAAGAGTC ATCTTGGAGGTGGCTGAGGTA NM_000499
CYP1A2 CACCTGCCTCTACAGTTGGTA GAAGCTCTGTGGCCGAGAAG NM_000761
SULT1A1 AGGAGTTCATGGACCACAGC TGAAGGTGGTCTTCCAGTCC NM_177536.2
UGT1A1 AATAAAAAAGGCTCTGCT ACATCAAACTGCTTTCTGC NM_000463
HPRT1 CTCCTGAGCAGTCAGCCCGC CACTAATCACGACGCCAGGGCT NM_000194
Primer Sequences of PhIP metabolizing enzymes
Uptake of [14C]-PhIP




























































Fig. 1 a Uptake of 5 mM PhIP + 0.1 mM [14C]-PhIP in Caco-2, HepG2
and adipocytes. (*p < 0.05) (b) Retention of 5 mM PhIP + 0.1 mM [14C]-
PhIP in Caco-2, HepG2 and adipocytes. Data presented as Mean ± SD.
(*p < 0.05 across time course)
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genotoxic DNA fragmentation was assessed by the
TUNEL assay. Figure 2 is a representative area of the slides
used by TUNEL assay for analysis (Fig. 2a = Caco-2 cells,
Fig. 2b =HepG2 cells and Fig. 2c =Adipocyte cells).
Unpaired t-test revealed statistical differences from controls
(p < 0.05) in the Caco-2 cells at 14.4 % (p = 0.002) and bor-
derline significance in the HepG2 cells at 2.6 % (p = 0.054).
There were no significant differences between control and
PhIP-treated adipocyte cells (p = 0.18).
Relative expression of PhIP-metabolizing enzymes in
cell lines
Since low level PhIP exposure did not induce cell death
in the adipocyte cell line, but did in Caco-2 and HepG2
cells, we then examined the expression levels of genes
involved in the metabolic activation of PhIP, and deter-
mined if exposure of the cell lines to PhIP could induce
the expression of these genes. Exposure of each cell line
to 5 nM PhIP did not significantly increase the expres-
sion of PhIP-metabolizing genes in any cell line tested
(Fig. 3a). We then compared baseline levels of CYP1A1,
CYP1A2, SULT1A1 and UGT1A1 in adipocytes, HepG2
and Caco-2 cell lines. Expression of CYP1A1 was 10-
and 100-fold higher in HepG2 and Caco-2 cell lines
compared to adipocytes, where expression of CYP1A1
was negligible. CYP1A2 expression was negligible in all
cell lines, while SULT1A1 and UGT1A1 were most
highly expressed in HepG2 cells (Fig. 3b). Exposure of
the cell lines to 5 nM PhIP did not result in any changes
in this observed pattern (Fig. 3c).
Global gene expression changes in h-MSC-derived
adipocytes exposed to PhIP
PhIP was taken up and retained to a greater degree by
adipocytes compared to HepG2 and Caco2; thus, we
sought to determine whether PhIP within the adipocyte
cell line remained inert, or exhibited biological effects.
Others have reported interactions of PhIP with both the
androgen and estrogen receptor at physiologically
achievable concentrations to induce the expression of
steroid-responsive genes [29–31]. Therefore, we then ex-
amined global gene expression in mature adipocytes. We
exposed mature adipocytes to varying concentrations of
PhIP (5 nM – 2.5 μM) for 72 h. Exposure to 5nM PhIP
resulted in significant differential expression of 64 genes
in an unadjusted model (Additional file 1: Table S1, see
end of document). After adjustment for multiple com-
parisons, 8 genes (ANGPTL2, CD14, CIDEA, EGR1,
FOS, IGFBP5, PALM and PSAT1) remained significant
at the p = 0.05 level (Table 2). Of the eight genes, four of
them (ANGPTL2, EGR1, FOS and IBP5) persisted to be
important in the gene-gene interaction analysis.
Gene-gene interaction and pathway analysis
To functionally validate the roles of these genes in bio-
logical pathways, the top significantly induced genes




Fig. 2 TUNEL assay of Vehicle or 5 μM PhIP exposure for 72 h cytotoxic damage in (a) Caco-2 (14.4 % higher than controls, p = 0.0019) (b) HepG2
(2.6 % higher than controls p = 0.0536) and (c) adipocyte (no differences from controls, p = 0.1790). Green spectrum are TUNEL positive objects,
blue spectrum are nuclei
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a
hMSC Derrived Adipocyte

































































































































































































































































































































































































Fig. 3 (See legend on next page.)
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compared to vehicle-treated controls (at p = 0.01) in the
unadjusted model were then subjected to gene-gene
interaction and pathway analysis. From this analysis, we
found that PhIP modulated genes controlled by the
STAT3 transcriptional factor (Fig. 4). Among genes con-
trolled by STAT3, exposure to PhIP resulted in the
down-regulation of early growth response 1 (EGR1) and
prostaglandin-endoperoxide synthase 2 (PTGS2) via c-
Fos, while insulin binding protein 5 (IBP5) was up regu-
lated. The expression of other transcription factors
(ANGPTL2, HP, LEP, SAA1, and SAA2) were up-
regulated by PhIP exposure. When direct interactions
were assessed, two genes were found to be down-
regulated (i.e. cFos, EGR1; p = 0.61E-05 and 1.25 E-05,
respectively), and IBP5 was upregulated (p = 0.014). Ana-
lysis also revealed two genes that are part of the gene-
gene interaction network, which are predicted to be
down regulated (i.e. PTGS2 and SGK1). Through gene-
gene interaction analysis we were able to reveal that the
down-regulated transcriptional factors cFOS and EGR1
that are downstream of MAPK signaling display direct
physical DNA-DNA interaction as predicted by Meta-
core software (Fig. 5) and elsewhere.
Discussion
This is the first report of PhIP mediating changes in
gene expression within the adipocyte. Along with other
heterocyclic amines, PhIP is lipophilic [22]. We hypothe-
sized that PhIP would be preferentially taken up by the
adipocyte and associate with the lipid droplet and not
undergo metabolic activation that leads to DNA damage.
In agreement with this hypothesis, PhIP in fact is not ac-
tivated in the adipocyte and does not cause cell death
measurable by TUNEL. Additionally, the adipocyte cell
line employed in these studies had negligible expression
of the enzymes necessary for metabolic activation, and
exposure to PhIP did not induce their expression. How-
ever, we did find that PhIP induces changes in gene
expression in various genes that are related to inflamma-
tion (SAA1, LEP), diabetes (IBP5) and cancer risk
(SAA2).
Reports in the literature support the role of adipose
tissue as sites of interaction with environmental chemi-
cals. It has long been recognized that persistent organic
pollutants (POPs) are sequestered in adipose tissue, and
this sequestration offers initial protection of other or-
gans and tissues from the harmful effects of these che-
micals. Over time, however, adiposity can increase the
body burden of POPs; weight loss and normal lipolysis
can then release these chemicals, resulting in tissue and
organ damage. Adipose is also a target of POPs and is
thought to participate in the mediation of the metabolic
effects of POPs (reviewed in [32]). In addition to POPs,
there are recent reports that Bisphenol-A (BPA), a
(See figure on previous page.)
Fig. 3 a Relative gene expression of PhIP metabolizing enzymes compared to controls after exposure to 5 nM PhIP for 72 h. Data is presented as
Mean ± SD *p < 0.05. Expression of CYP1A1 (p = 0.0511, p = 0.5459, p = 0.1615), CYP1A2 (p = 0.1194, p = 0.6966, p = 0.4045), SULT1A1 (p = 0.0866, p =
0.4488, p = 0.6952) and UGT1A1 (p = 0.1719, p = 0.5599, p = 0.3261) in Adipocyte, HepG2 and Caco-2 cells respectively. There were no significant
differences from controls. b Relative gene expression of baseline PhIP metabolizing enzymes normalized to adipocyte controls. Data is
presented as Mean ± SD *p < 0.05. Expression of CYP1A1 (p = 0.0030, p = 0.0055), CYP1A2 (p = 0.0044, p = 0.0047), SULT1A1 (p = 0.0001, p = 0.0358) and
UGT1A1 (p = 0.0104, p = 0.0001) in HepG2 and Caco-2 cells respectively. HepG2 and Caco-2 cells had significantly higher baseline PhIP metabolizing
enzymes than adipocytes with the exception of CYP1A2. c Relative gene expression of PhIP metabolizing enzymes after 5nM PhIP exposure, normalized to
adipocyte treatment. Data is presented as Mean ± SD *p< 0.05. Expression of CYP1A1 (p = 0.0030, p = 0.0037), CYP1A2 (p = 0.0140, p = 0.3050),
SULT1A1 (p = 0.0005, p = 0.0516) and UGT1A1 (p = 0.0001, p = 0.0754) in HepG2 and Caco-2 cells respectively. HepG2 cell expression was
significantly higher than the adipocyte in all four PhIP metabolizing enzymes while Caco-2 was significantly higher in the CYP1A1
enzyme only
Table 2 Differential expression of genes in h-MSC-derived adipocytes exposed to PhIP
Gene Symbol Accession Ave Expression FC P.Value adj.P.Val
ANGPTL2a NM_012098.2 8.578 1.88 6.19E-07 0.59E-04
EGR1a NM_001964.2 8.750 -2.93 2.65E-10 1.25E-05
FOSa NM_005252.2 7.120 -1.95 2.57E-08 0.61E-05
IBP5a NM_000599.2 8.550 1.91 2.45E-06 0.014
CIDEA NM_001279.2 6.697 1.49 3.24E-07 0.39E-04
PALM NM_002579.2 8.575 1.63 4.06E-06 0.018
PSAT1 NM_021154.3 8.614 -1.62 4.26E-06 0.018
CD14 NM_001040021.1 7.650 1.58 1.93E-05 0.05
Differentially expressed genes in hMSC derived adipocyte exposed to 5 nM PhiP for 72 h, adjusted for multiple comparisons, significant at the p = 0.05 level
aReceptor ligands, transcriptional factors and/or binding proteins that are significant and are controlled by the STAT3 transcriptional factor in the gene-gene inter-
action and pathway analyses (see Figs. 4 and 5)
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known endocrine disrupting chemical, can regulate the
expression of genes within adipocytes that participate in
metabolic homeostasis and obesity [33]. Efforts to limit
exposures to these chemicals have received much atten-
tion. There have also been efforts to reduce the consump-
tion of red and processed meats based on their association
with cancer, cardiovascular disease and diabetes [34]. And
while obesity is a risk factor for these diseases as well, the
potential effect of food-borne HCAs such as PhIP on adi-
pocyte function has been unrecognized. The observation
that PhIP induces gene expression changes in important
pathways could have profound implications in human
health, particularly in Western countries where the con-
sumption of well-done cooked meat is common. And ana-
lysis of world meat consumption patterns documents a
surge in meat consumption by emerging countries such as
China and Brazil [35].
Analysis of global gene expression revealed that low
levels of PhIP perturbed pathways related to obesity, in-
flammation, diabetes and risk of certain cancers. For ex-
ample, cFOS positively binds and activates STAT3,
which positively activates EGR1, cFOS, and PTGS2
Fig. 4 5 nM PhIP activates STAT3-mediated transcriptional regulation. Genes within the STAT3 pathway were modulated by exposure to 5 nM
PhIP for 72 h. One star denotes significance at <0.05 in the unadjusted model and two stars denote significance at <0.05 after adjustment for
multiple comparisons
Fig. 5 Direct interactions between genes induced or suppressed by 5nM PhIP exposure. One star denotes significance at <0.05 in the unadjusted
model and two stars denote significance at <0.05 after adjustment for multiple comparisons
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(COX-2). PhIP exposure suppressed this pathway, while
it induced the expression of IBP5, a biomarker of obesity
[36, 37], suggesting that the effects of PhIP exposure are
complex. However, STAT3 can physically bind to and
positively activate serum amyloid A1 binding proteins
A1 and A2 (SAA1, SAA2) and these proteins were up-
regulated by PhIP exposure. SAA1 encodes a member of
the serum amyloid A family of apolipoproteins, which is
a major acute phase protein that is highly expressed in
response to inflammation and tissue injury [38, 39].
SAA1 also plays an important role in high density lipo-
protein (HDL) metabolism and cholesterol homeostasis
[40]. High levels of this protein are associated with
chronic inflammatory diseases [38]. SAA2 may also be a
potential biomarker for certain tumors [41, 42]. In the
present study, these genes were significantly modulated
in the unadjusted models, and some retained signifi-
cance when adjusted for multiple comparisons. Future
studies in our laboratory will explore the impact of PhIP
exposure under varied experimental conditions to deter-
mine the exact contributions of pathway genes to the ef-
fects of PhIP on adipocytes.
The magnitude of changes in gene expression was
modest in this report, but a strength of the current study
is that the PhIP concentrations examined approach diet-
ary relevance in humans. PhIP daily intake estimates
range from 0 to 630 ng/day according to meat-specific
food frequency questionnaires (FFQs) and diet diaries
coupled with the NCI Computerized Heterocyclic
Amines Resource for Research in Epidemiology of
Disease (CHARRED), [43, 44]. By examining low doses
of PhIP, we more closely approach levels that could be
expected in human populations. While we only reported
on the effects of 5 nM PhIP, concentrations ranging up
to 100 μM were also examined. Interestingly, as PhIP
concentrations increased, the numbers of genes and
pathways that were significantly changed decreased. This
suggests that in vitro studies employing high, non-
physiological concentrations may not identify important
interactions. We also measured changes that occurred
after relatively short time intervals; effects of long-term,
low-dose exposures are unclear and are the subject of
further investigation in our laboratory.
Nonetheless, the observation that PhIP is mediating
gene expression changes within the adipocyte, and that
the pathways most affected are related to cancer and other
chronic disease is intriguing. The established paradigm of
PhIP-induced carcinogenesis involves metabolic activation
[45], DNA adduct formation resulting in deleterious mu-
tations that initiate carcinogenesis [28, 46–48]. However,
there are reports in the literature of PhIP interacting with
both the estrogen and androgen receptor at physiologic-
ally achievable concentrations [29–31], indicating that
DNA adduct formation is only one pathway of PhIP
effects, and perturbation of the microenvironment pro-
duced by adiposity could generate changes conducive to
cancer and other chronic diseases.
Conclusions
The observation that PhIP is mediating gene expression
changes within the adipocyte, and that the pathways
most affected are related to cancer and other chronic
disease suggests studies that address mechanisms other
than DNA adduct formation are needed to clarify the re-
lationship between dietary carcinogens such as PhIP
with cancer, obesity and diabetes.
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